679 related articles for article (PubMed ID: 27994459)
21. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
22. PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation.
Shah P; Sarolia J; Vyas B; Wagh P; Ankur K; Kumar MA
Curr Drug Deliv; 2021; 18(6):805-824. PubMed ID: 32640955
[TBL] [Abstract][Full Text] [Related]
23. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
Sharma S; Lohan S; Murthy RS
Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
[TBL] [Abstract][Full Text] [Related]
24. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
Ahmad N; Ahmad R; Naqvi AA; Alam MA; Ashafaq M; Samim M; Iqbal Z; Ahmad FJ
Int J Biol Macromol; 2016 Oct; 91():640-55. PubMed ID: 27264648
[TBL] [Abstract][Full Text] [Related]
25. Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.
Mistry A; Stolnik S; Illum L
Mol Pharm; 2015 Aug; 12(8):2755-66. PubMed ID: 25997083
[TBL] [Abstract][Full Text] [Related]
26. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
[TBL] [Abstract][Full Text] [Related]
27. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
[TBL] [Abstract][Full Text] [Related]
28. Optimization of artemether-loaded NLC for intranasal delivery using central composite design.
Jain K; Sood S; Gowthamarajan K
Drug Deliv; 2015; 22(7):940-54. PubMed ID: 24512368
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study.
Khan A; Aqil M; Imam SS; Ahad A; Sultana Y; Ali A; Khan K
Int J Biol Macromol; 2018 Sep; 116():1260-1267. PubMed ID: 29775717
[TBL] [Abstract][Full Text] [Related]
31. Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation.
Salem HF; Aboud HM; Abdellatif MM; Abou-Taleb HA
J Pharm Sci; 2024 Jul; 113(7):1934-1945. PubMed ID: 38369023
[TBL] [Abstract][Full Text] [Related]
32. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
[TBL] [Abstract][Full Text] [Related]
33. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
[TBL] [Abstract][Full Text] [Related]
34. Development and in vitro/in vivo evaluation of HPMC/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent.
Varshosaz J; Taymouri S; Minaiyan M; Rastegarnasab F; Baradaran A
Drug Dev Ind Pharm; 2018 Feb; 44(2):276-288. PubMed ID: 29043860
[TBL] [Abstract][Full Text] [Related]
35. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
Haque S; Md S; Fazil M; Kumar M; Sahni JK; Ali J; Baboota S
Carbohydr Polym; 2012 Jun; 89(1):72-9. PubMed ID: 24750606
[TBL] [Abstract][Full Text] [Related]
36. Topical hydrogel matrix loaded with Simvastatin microparticles for enhanced wound healing activity.
Yasasvini S; Anusa RS; VedhaHari BN; Prabhu PC; RamyaDevi D
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():160-167. PubMed ID: 28024572
[TBL] [Abstract][Full Text] [Related]
37. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
38. Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration.
Di Cola E; Cantu' L; Brocca P; Rondelli V; Fadda GC; Canelli E; Martelli P; Clementino A; Sonvico F; Bettini R; Del Favero E
Colloids Surf B Biointerfaces; 2019 Nov; 183():110439. PubMed ID: 31473410
[TBL] [Abstract][Full Text] [Related]
39. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model.
Rizvi SZH; Shah FA; Khan N; Muhammad I; Ali KH; Ansari MM; Din FU; Qureshi OS; Kim KW; Choe YH; Kim JK; Zeb A
Int J Pharm; 2019 Apr; 560():136-143. PubMed ID: 30753932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
